Similarly, Cai et al., in their investigation of liraglutide’s effects on diabetic cardiomyopathy, identified a correlation between FOXO1 expression and the GLP-1/GLP-1R axis. The gene discussed is FOXO1; the disease is diabetic cardiomyopathy.